March 11, 2026 a 11:43 am

JNJ: Fundamental Ratio Analysis - Johnson & Johnson

Johnson & Johnson Stock Analysis

Johnson & Johnson is a prominent player in the healthcare industry, having strategically refocused on its Innovate Medicine and MedTech segments after separating its Consumer Health business into Kenvue Inc. This strategic pivot aims to capitalize on higher-growth areas with an innovation-driven approach. Investors may find JNJ interesting due to its longstanding commitment to human health and its robust array of advanced medical solutions.

Fundamental Rating

Johnson & Johnson has received strong fundamental scores, reflecting its solid financial health and operations. Below are the detailed ratings in key categories:

Category Score Visualization
Discounted Cash Flow 4
Return On Equity 5
Return On Assets 5
Debt To Equity 2
Price To Earnings 2
Price To Book 1

Historical Rating

The historical ratings illustrate a consistent performance with slight adjustments over time.

Date Overall DCF ROE ROA D/E P/E P/B
2026-03-10 3 4 5 5 2 2 1
Previous 0 4 5 5 2 2 1

Analyst Price Targets

Analyst estimates indicate a healthy outlook with varied price targets.

Price Target Value
High 265
Low 190
Median 220
Consensus 229.33
JNJ Stock Price Chart

Analyst Sentiment

The current analyst sentiment shows a positive tilt towards buying the stock.

Recommendation Count Visualization
Strong Buy 0
Buy 20
Hold 16
Sell 3
Strong Sell 0

Conclusion

Johnson & Johnson remains a robust investment option, with solid fundamentals and a positive outlook from analysts. The company's focused strategy on innovative healthcare solutions positions it well for future growth. However, potential investors should be mindful of sector and company-specific risks that may impact performance. The historical performance indicates consistency, and the current analyst sentiment suggests a generally favorable view on future stock performance.